SecBot SecBot
8-K ·Filed Aug 25, 2026

BTAI

BioXcel Therapeutics, Inc.
BEARISH
Impact 8/10
Horizonimmediate Processed2mo ago SEC0001104659-26-100532
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight ▼ Bearish

With a $25M market cap, $250K minimum liquidity threshold, and a forced August 31 deadline for a restructuring/sale transaction, BTAI faces acute near-term default and dilution risk. The 20% upfront fee on new loans signals extremely distressed credit pricing. Traders should monitor for an asset sale, license deal, or reverse merger announcement before the deadline — any further delay or failure to reach a deal likely triggers an event of default and potential bankruptcy filing.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+5d
BTAI ▼ -81.54% at T+5d
SHORT call ✓ call won +81.54% · α vs SPY +81.00% · entry $0.7422 → $0.1370
Next anchor: T+20d due 5w ago
Entry = T+0 close
Aug 25, 2026
via day close
T+1d
+5.09%
call -5.09% · α -5.07%
$0.7800
settled 2mo ago
T+5d
-81.54%
call +81.54% · α +81.00%
$0.1370
settled 8w ago
T+20d
Pending
due 5w ago
T+60d
Pending
in 22d

Price Chart

Loading chart...

Executive Summary

BioXcel Therapeutics entered into the Fourteenth Amendment to its Oaktree-led credit agreement, securing $1.25M in additional term loans (net $1.0M after a 20% upfront fee) and reducing the minimum liquidity covenant from $3.0M to just $250K. The amendment also requires the company to enter into definitive agreements by August 31, 2026 for a transaction that repays all obligations or an acceptable alternative capital solution, and tightens covenants on out-licensing and asset sales. This is a distressed debt action signaling acute liquidity pressure and a forced near-term restructuring or sale.

Key Financial Metrics

Deal Value
$1.3M
Deal Type
credit_facility

Key Facts

  • Additional loans of $1,250,000 were made, but the company paid a $250,000 upfront fee (20% of principal), netting only ~$1.0M in incremental cash.
  • Minimum liquidity covenant slashed from $3.0 million to $250,000, indicating critically low cash reserves.
  • Company must enter definitive agreements for a repayment or alternative capital transaction by August 31, 2026 — just 6 days after the amendment.
  • Covenants on out-licensing of IP and asset sales were tightened, reflecting lender concerns about asset stripping or value leakage.
  • Total loan facility increased from $202,319,447 to $203,569,447 to incorporate the new term loan.
  • The amendment includes plan support provisions for an insolvency scenario, with QIA Lender agreeing not to object to a §363 sale and to support any restructuring plan approved by Oaktree Lenders.

Financial Impact

$1.25M additional term loan with $250K upfront fee; minimum liquidity reduced to $250K; total facility now $203.57M

liquidityleveragedebt maturity timelinecovenant headroom

Risk Factors

  • Failure to enter acceptable definitive agreements by August 31, 2026 could trigger an immediate event of default and acceleration of the full $203.6M debt.
  • The $250K liquidity floor means the company has almost no cash buffer — any operational disruption or payment delay could force insolvency.
  • Tightened covenants on IP out-licensing and asset sales limit the company's options for raising capital or selling assets to repay debt.
  • Plan support provisions suggest lenders are already preparing for a potential Chapter 11 filing, which would likely wipe out common equity.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-100532
Document: 0001104659-26-100532-index.html0001104659-26-100532
Document: 0001104659-26-100532.txt0001104659-26-100532
14 reports for BTAI
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 9 of 9 best @ T+20▲ +95.39%Aug 11, 2026
Filters
Rows
Reports for BTAI — sortable, filterable
TypeNow
Sep 1, 2026
7w ago
8-K
BEARISH ★ 9/10
$0.1370awaiting T+60——
Aug 28, 2026
8w ago
Press Release
BEARISH ★ 9/10
$0.1814awaiting T+60——
Aug 25, 2026
8w ago
8-K
BEARISH ★ 8/10
$0.7422awaiting T+60——
Aug 11, 2026
10w ago
8-K
BEARISH ★ 7/10
$0.9320awaiting T+60——
Aug 3, 2026
12w ago
8-K
BEARISH ★ 7/10
$0.8480awaiting T+60——
Jul 6, 2026
16w ago
8-K
BEARISH ★ 7/10
$1.10awaiting T+60——
May 22, 2026
22w ago
Insider Cluster
BEARISH ★ 5/10
$1.22 $0.8274▲ +32.18%▲ +34.91%—
May 20, 2026
22w ago
144
NEUTRAL ★ 2/10
$1.14 $0.8900▼ −21.93%▼ −26.23%—
May 15, 2026
23w ago
8-K
NEUTRAL ★ 6/10
$1.14 $0.9319▼ −18.25%▼ −22.77%—
May 15, 2026
23w ago
Press Release
BEARISH ★ 6/10
$1.14 $0.9319▲ +18.25%▲ +22.77%—
Showing 10 of 14

US Market Status

Market Closed — Opens in 2h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 25, 2026